Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance

References

• KrogerNAchterrathWHegewisch-BeckerSMrossKZanderARCurrent options in treatment of anthracycline-resistant breast cancerCancer Treat Rev199925527929110544072
   PubMed Web of Science ®Google Scholar
• NaitoSYokomizoAKogaHMechanisms of drug resistance in chemotherapy for urogenital carcinomaInt J Urol19996942743910510888
   PubMedGoogle Scholar
• GilletJ-PGottesmanMMMechanisms of multidrug resistance in cancerZhouJMulti-Drug Resistance in Cancer596Totowa (NJ)Humana Press Inc20104776
   Google Scholar
• FieldsAHochsterHRunowiczCPSC833: initial clinical results in refractory ovarian cancer patientsCurr Opin Oncol199810Suppl 1S219988540
   PubMedGoogle Scholar
• WiglerPWPSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblastsBiochem Biophys Res Commun1999257241041310198227
   PubMedGoogle Scholar
• VerschraegenCFGuptaFLoyerEA phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerAnti-Cancer Drugs199910437538310378672
   PubMed Web of Science ®Google Scholar
• CruzFWolfAEffects of the novel cyclosporine derivative PSC833 on glucose metabolism in rat primary cultures of neuronal and glial cellsBiochem Pharmacol200162112913911377404
   PubMedGoogle Scholar
• BaekelandtMLehneGTropeCGPhase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancerJ Clin Oncol200119122983299311408493
   PubMedGoogle Scholar
• ChicoIKangMHBerganRPhase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833J Clin Oncol200119383284211157037
   PubMed Web of Science ®Google Scholar
• BaguleyBCMultiple drug resistance mechanisms in cancerMol Biotechnol201046330831620717753
   PubMed Web of Science ®Google Scholar
• AdlerLMHerzogTJWilliamsSRaderJSMutchDGAnalysis of exposure times and dose-escalation of paclitaxel in ovarian-cancer cell-linesCancer1994747189118987915965
   PubMedGoogle Scholar
• GuastallaJPLhommeCDauplatJTaxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: an interim analysis of a phase II multicenter studyAnn Oncol19945Suppl 6S33S387865432
   PubMedGoogle Scholar
• KubotaTMatsuzakiSWHoshiyaYAntitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude miceJ Surg Oncol19976421151219047247
   PubMedGoogle Scholar
• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm20022351–217919211879753
   PubMed Web of Science ®Google Scholar
• LiuYHuangLLiuFPaclitaxel nanocrystals for overcoming multi-drug resistance in cancerMol Pharm20107386386920420443
   PubMed Web of Science ®Google Scholar
• MathewAEMejillanoMRNathJPHimesRHStellaVJSynthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor-activityJ Med Chem19923511451511346275
   PubMed Web of Science ®Google Scholar
• WangYZYuLHanLMShaXYFangXLDifunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and pluronic-mediated overcoming multidrug resistance in tumor cell linesInt J Pharm20073371–2637317289311
   PubMed Web of Science ®Google Scholar
• Van VlerkenLEDuanZFLittleSRSeidenMVAmijiMMAugmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systemsAAPS J201012217118020143195
   PubMed Web of Science ®Google Scholar
• PunfaWSuzukiSPitchakarnPCurcumin-loaded PLGA nanoparticles conjugated with anti-P-glycoprotein antibody to overcome multidrug resistanceAsian Pac J Cancer Prev201415219249925825422208
   PubMedGoogle Scholar
• WangNHeTShenYMPaclitaxel and tacrolimus coencapsulated polymeric micelles that enhance the therapeutic effect of drug-resistant ovarian cancerACS Appl Mater Interfaces2016874368437726809267
   PubMed Web of Science ®Google Scholar
• WangYZLiYJWangQSWuJFangXLPharmacokinetics and biodistribution of paclitaxel-loaded Pluronic P105/L101 mixed polymeric micellesYakugaku Zasshi2008128694195018520140
   PubMedGoogle Scholar
• ZhangWShiYAChenYZYeJAShaXYFangXLMultifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumorsBiomaterials201132112894290621256584
   PubMed Web of Science ®Google Scholar
• WangYZHaoJGLiYJPoly (caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumorsBiomaterials201233184741475122445254
   PubMed Web of Science ®Google Scholar
• WeiXLLiangWNanostructrue and function of PEGylated phospholipid micelles encapsulation drugsProg Biochem Biophys20134010948954
   Google Scholar
• TangNDuGJWangNLiuCCHangHYLiangWImproving penetration in tumors with nanoassemblies of phospholipids and doxorubicinJ Natl Cancer Inst200799131004101517596572
   PubMedGoogle Scholar
• WangJXingXQFangXCCationic amphiphilic drugs self-assemble to the core-shell interface of PEGylated phospholipid micelles and stabilize micellar structurePhilos Trans A Math Phys Eng Sci2013371200017
   Google Scholar
• FangXCYangTWangLYNano-cage-mediated refolding of insulin by PEG-PE micelleBiomaterials20167713914826595505
   PubMed Web of Science ®Google Scholar
• SonSSinghaKKimWJBioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrierBiomaterials201031246344635420537703
   PubMed Web of Science ®Google Scholar
• OumzilKKhiatiSGrinstaffMWBarthelemyPReduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coatingJ Control Release2011151212313021354443
   PubMed Web of Science ®Google Scholar
• ZhangZPTanSWFengSSVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
   PubMed Web of Science ®Google Scholar
• CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
   PubMed Web of Science ®Google Scholar
• ShiehMJHsuCYHuangLYChenHYHuangFHLaiPSReversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cellsJ Control Release2011152341842521435362
   PubMed Web of Science ®Google Scholar
• GuoYYChuMTanSWChitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistanceMol Pharm2014111597024229050
   PubMedGoogle Scholar
• ChenSYDongQHuSSProteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cellsMol Biosyst201410229430324292090
   PubMedGoogle Scholar
• LeeJWLeeSCAcharyaGChangCJParkKHydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic propertyPharm Res20032071022103012880288
   PubMed Web of Science ®Google Scholar
• SimonLSzilagyiGBoriZTelekGMagyarKNagyZLow dose (−) deprenyl is cytoprotective: it maintains mitochondrial membrane potential and eliminates oxygen radicalsLife Sci200578322523116242156
   PubMedGoogle Scholar
• DintamanJMSilvermanJAInhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS)Pharm Res199916101550155610554096
   PubMed Web of Science ®Google Scholar
• YumotoRMurakamiTNakamotoYHasegawaRNagaiJTakanoMTransport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compoundsJ Pharmacol Exp Ther1999289114915510086998
   PubMed Web of Science ®Google Scholar
• MistryPStewartAJDangerfieldWIn vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576Cancer Res200161274975811212278
   PubMed Web of Science ®Google Scholar
• FengSSChienSChemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChem Eng Sci2003581840874114
   Web of Science ®Google Scholar
• CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
   PubMed Web of Science ®Google Scholar
• WuGYFangYZYangSLuptonJRTurnerNDGlutathione metabolism and its implications for healthJ Nutr2004134348949214988435
   PubMed Web of Science ®Google Scholar
• ChengRFengFMengFHDengCFeijenJZhongZYGlutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJ Control Release2011152121221295087
   PubMed Web of Science ®Google Scholar
• WenHYDongHQXieWJRapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug deliveryChem Commun2011471235503552
   PubMed Web of Science ®Google Scholar
• SunHLGuoBNChengRMengFHLiuHYZhongZYBiodegradable micelles with sheddable poly (ethylene glycol) shells for triggered intracellular release of doxorubicinBiomaterials200930316358636619666191
   PubMed Web of Science ®Google Scholar
• ZhangZPFengSSThe drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)-tocopheryl polyethylene glycol succinate nanoparticlesBiomaterials200627214025403316564085
   PubMed Web of Science ®Google Scholar
• PanJFengSSTargeted delivery of paclitaxel using folate-decorated poly (lactide) – vitamin E TPGS nanoparticlesBiomaterials200829172663267218396333
   PubMed Web of Science ®Google Scholar
• NaCSi-ShenFDoxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluationBiomaterials200829283856386518606445
   PubMedGoogle Scholar
• Chee WeeGSi-ShenFTransferrin-conjugated nanoparticles of poly (lactide)-d-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrierBiomaterials201031307748775720673685
   PubMedGoogle Scholar
• SunFHuoXZhaiYJCrystal structure of mitochondrial respiratory membrane protein complex IICell200512171043105715989954
   PubMed Web of Science ®Google Scholar
• SuZGChenMLXiaoYYROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor’s multidrug resistanceJ Control Release201419637038325278256
   PubMed Web of Science ®Google Scholar
• AlmeidaJBallBAEffect of alpha-tocopherol and tocopherol succinate on lipid peroxidation in equine spermatozoaAnim Reprod Sci2005873–432133715911181
   PubMed Web of Science ®Google Scholar
• YoukHJLeeEChoiMKEnhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycolJ Control Release20051071435216081183
   PubMed Web of Science ®Google Scholar
• KolkerSSchwabMHorsterFMethylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chainJ Biol Chem200327848473884739312972416
   PubMed Web of Science ®Google Scholar
• MbayaEOulesBCaspersenCCalcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiencyCell Death Differ201017121855186620489732
   PubMed Web of Science ®Google Scholar
• WangYGuoMLuYAlpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitroNanotechnology2012234914
   Google Scholar
• AssanhouAGLiWYZhangLReversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatmentBiomaterials20157328429526426537
   PubMed Web of Science ®Google Scholar
• Perez-TomasRMultidrug resistance: retrospect and prospects in anticancer drug treatmentCurr Med Chem200613161859187616842198
   PubMed Web of Science ®Google Scholar